Cedar Grove Capital Management

Cedar Grove Capital Management

Portfolio Updates

Update on Recent HIMS News, MAMA Q3'24 Earnings, and Other Portfolio Changes

Portfolio Update #9

Paul Cerro's avatar
Paul Cerro
Dec 22, 2024
∙ Paid
3
1
Share
It's not a paid ad but I just wanted to let everyone know that if you’re wondering what I use to get my information for my research, it’s largely Koyfin. If you’re interested in checking it out (I highly recommend it), you can get 20% off your plan using my link here.
As a reminder, if you’re a student, you also get an annual subscription for $52/yr (vs. $350) if you use your school email. Just click through with this link.

Hello investors,

Today I’m going to keep it limited to just updating you all on recent Hims & Hers Health (HIMS) news regarding the FDA and the pricing changes we saw on Friday as well as our take on the recent Mama’s Creations (MAMA) Q3’24 earnings and a brief portfolio update.

We’re looking to end the year with a bang and given that HIMS is one of our larger, more “at risk” positions, we felt a more thorough update was warranted.

With that, let’s get started.


Hims & Hers Health (HIMS)

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Paul Cerro
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture